- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06553508
Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 Days
Study Overview
Status
Intervention / Treatment
Detailed Description
During total hip arthroplasty surgery, the trochanteric bursa is routinely excised. This anatomical structure, which functions as a soft tissue barrier, is typically recommended for removal as it facilitates the surgical approach. However, recent studies have suggested that the trochanteric bursa is an important soft tissue barrier and may provide protection against infections. The aim of this study is to evaluate the differences in infection rates, wound complications, deep gluteal syndrome presence, pain, and clinical scores within the first 90 days between patients in whom the trochanteric bursa was repaired and those in whom it was not, and to provide recommendations regarding bursal repair.
This research will be a prospective randomized controlled trial with patients subjected to sequential randomization. One group of patients will undergo the routine excision of the bursa during surgery, referred to as Group 1. In the other group, the trochanteric bursa will be carefully retracted and subsequently repaired in its anatomical location beneath the fascia after the surgical procedure. Wound closure will be performed routinely, with subcutaneous and skin closure. All patients will have a Hemovac drain placed, and they will follow the same rehabilitation protocol.
Patients will be evaluated on postoperative days15, 30, and 90 using Visual Analog Scale scores, and on days 30 and 90 using the Harris Hip Score. Additionally, patients will be assessed for tenderness on palpation, the presence of hip snapping (a sensation of the hip catching), hemoglobin drop, 90-day infection rates, and the presence of deep gluteal syndrome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06800
- Ankara Bilkent City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients between 18 to 90 years of age
- With a diagnosis of primary hip osteoarthritis
- Willing to be included in the study
Exclusion Criteria:
- Patients who had a known history of trochanteric bursitis, deep gluteal syndrome, sciatica, vertebral fracture, hip fracture, hip arthroscopy, and core decompression surgery
- Patients who had a history of bursal injection within 6 months
- Patients undergoing hip arthroplasty with a shortening osteotomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Unrepaired bursa group
As a routine procedure in our centre, the trochanteric bursa is left unrepaired after a hip arthroplasty.
The conventional joint closure is performed after reduction and the layers are closed in a routine fashion.
|
For the experimental arm, the trochanteric bursa is repaired after a hip arthroplasty.
The conventional joint closure is performed after reduction and then the bursa is retrieved and repaired.
|
|
Experimental: Repaired Bursa group
For the experimental arm, the trochanteric bursa is repaired after a hip arthroplasty.
The conventional joint closure is performed after reduction and then the bursa is retrieved and repaired.
Layers are then closed in a routine fashion.
|
As a routine procedure in our centre, the trochanteric bursa is left unrepaired after a hip arthroplasty.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of superficial wound problems
Time Frame: First postoperative 90 days
|
Wound leakage, superficial infection, wound dehiscence - Recorded as Yes / No
|
First postoperative 90 days
|
|
Rate of posterior gluteal pain
Time Frame: First postoperative 90 days
|
The condition is also refered to as Deep Gluteal Syndrome - Recorded as Yes / No
|
First postoperative 90 days
|
|
Rate of painful trochanteric bursitis
Time Frame: First postoperative 90 days
|
Recorded as pain on the trochanteric region on palpation - Recorded as Yes / No
|
First postoperative 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of motion (ROM)
Time Frame: First postoperative 90 days
|
Angular measurement of hip joint motion - minimum value:0, maximum value 130, higher values mean better outcome
|
First postoperative 90 days
|
|
Visual Analog Scale (VAS)
Time Frame: First postoperative 90 days
|
minimum value:0, maximum value 10, higher values mean worse outcome
|
First postoperative 90 days
|
|
Harris Hip Score (HHS)
Time Frame: First postoperative 90 days
|
minimum value:0, maximum value 100, higher values mean better outcome
|
First postoperative 90 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Enejd Veizi, MD, Ankara Bilkent City Hospital
Publications and helpful links
General Publications
- Schwartsmann CR, Loss F, de Freitas Spinelli L, Furian R, Silva MF, Zanatta JM, Boschin LC, Goncalves RZ, Yepez AK. Association between trochanteric bursitis, osteoarthrosis and total hip arthroplasty. Rev Bras Ortop. 2014 Apr 25;49(3):267-70. doi: 10.1016/j.rboe.2014.04.009. eCollection 2014 May-Jun.
- Shemesh SS, Moucha CS, Keswani A, Maher NA, Chen D, Bronson MJ. Trochanteric Bursitis Following Primary Total Hip Arthroplasty: Incidence, Predictors, and Treatment. J Arthroplasty. 2018 Apr;33(4):1205-1209. doi: 10.1016/j.arth.2017.11.016. Epub 2017 Nov 13.
- Moerenhout K, Benoit B, Gaspard HS, Rouleau DM, Laflamme GY. Greater trochanteric pain after primary total hip replacement, comparing the anterior and posterior approach: A secondary analysis of a randomized trial. Orthop Traumatol Surg Res. 2021 Dec;107(8):102709. doi: 10.1016/j.otsr.2020.08.011. Epub 2020 Oct 31.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E2-21-1124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Disease
-
FH ORTHOTerminatedHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
JointMedica Inc.Active, not recruitingOsteoarthritis of the Hip | Degenerative Joint Disease of Hip | Dysplasia; HipUnited States, Bermuda
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Istituto Ortopedico GaleazziCompleted
-
Assiut UniversityNot yet recruiting
-
JRI OrthopaedicsRecruiting
-
Hospital for Special Surgery, New YorkCompletedHip DiseaseUnited States
-
University of Colorado, DenverCompletedHip DiseaseUnited States
Clinical Trials on Trochanteric bursa unrepaired
-
Elda University HospitalRecruiting
-
University of Alabama at BirminghamSmith & Nephew, Inc.CompletedFemur FractureUnited States
-
Ludwig-Maximilians - University of MunichUnknownTraumatic Laceration of the Olecranon or Prepatellar BursaAustria, Germany
-
West Virginia UniversityCompleted
-
Superior UniversityRecruitingSacroiliac Joint DysfunctionPakistan
-
Johns Hopkins UniversityCompleted
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
National Institute on Aging (NIA)Completed
-
DePuy OrthopaedicsCompletedFemoral Fracture (Proximal)United States
-
University Hospital, GhentCompletedPertrochanteric and Subtrochanteric Femur FracturesBelgium